New York Oncology Hematology — Albany, New York

New York Oncology Hematology is a clinical research site located in Albany, New York, United States 12065.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

New York Oncology Hematology has participated in 33 clinical trials with 10 currently active.

Therapeutic areas: Breast Cancer, Non-small Cell Lung Cancer, Ovarian Cancer.

Sponsors: Greenwich LifeSciences, Inc., Stemline Therapeutics, Inc., Heat Biologics.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Oncology Hematology?

New York Oncology Hematology has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Oncology Hematology conducted?

New York Oncology Hematology has 33 clinical trials on record, with 10 currently active. Their work covers Breast Cancer, Non-small Cell Lung Cancer, Ovarian Cancer.

Is New York Oncology Hematology accredited by Crixeo Health?

Yes — New York Oncology Hematology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about New York Oncology Hematology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.